Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-540-6 | CAS number: 16485-10-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-07-01
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- July 21, 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- December 1992
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- his operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- not applicable
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor 1254-induced rat liver S-9
- Test concentrations with justification for top dose:
- 20, 100, 500, 2500, 5000 µg/plate (SPT and PIT)
- Vehicle / solvent:
- - Vehicle used: water
- Justification for choice of solvent/vehicle: Due to the good solubility of the test substance in water, water was selected as the vehicle. - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene, N-methyl-N'-nitro-N-nitrosoguanidine, 4-nitro-o-phenylendiamine, 9-aminoacridine, 4-nitroquinoline-N-oxide
- Remarks:
- positive control substance depending on tester strain and activation conditions
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: plate incorporation
DURATION
- Exposure duration: 48 - 72 h, 37°C, in the dark
NUMBER OF REPLICATIONS: 3 plates per dose or per control
DETERMINATION OF CYTOTOXICITY
- Method: decrease in the number of revertants, clearing or diminution of the background lawn (= reduced his- or trp+ background growth), reduction in the titer
METHOD OF APPLICATION: preincubation
DURATION
- Preincubation period: 20 min., 37°C
- Exposure duration: 48 - 72 h, 37°C, in the dark
NUMBER OF REPLICATIONS: 3 plates per dose or per control
DETERMINATION OF CYTOTOXICITY
- Method: decrease in the number of revertants, clearing or diminution of the background lawn (= reduced his- or trp+ background growth), reduction in the titer - Evaluation criteria:
- Acceptance criteria
Generally, the experiment is to be considered valid if the following criteria are met:
The number of revertant colonies in the negative controls was within the normal range of the historical control data for each tester strain.
The sterility controls revealed no indication of bacterial contamination.
The positive control articles both with and without S-9 mix induced a significant increase in the number of revertant colonies within the range of the historical control data.
The titer of viable bacteria was >10E9/ml.
Evaluation criteria
The test chemical is considered positive in this assay if the following criteria are met:
A dose-related and reproducible increase in the number of revertant colonies, i.e. about doubling of the spontaneous mutation rate in at least one tester strain either without S-9 mix or after adding a metabolizing system.
A test substance is generally considered nonmutagenic in this test if:
The number of revertants for all tester strains were within the historical negative control range under all experimental conditions in two experiments carried out independently of each other. - Statistics:
- no data
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- No increase in the number of revertants was observed with any tester strain at any concentration in the absence and presence of metabolic activation. No bacteriotoxicity was observed. The test substance was completely soluble in the vehicle; no precipitation was noted.
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative
According to the results of the present study, the test substance DL-Panthenol is not mutagenic in the Salmonella typhimurium/Escherichia coli reverse mutation assay under the experimental conditions chosen here. - Executive summary:
The substance DL-Panthenol was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay according to OECD 471 and under GLP.
Standard plate test (SPT) and Preincubation Test (PIT) both with and without metabolic activation with liver homogenate of Aroclor 1254 -pretreated male Sprague-Dawley rats were applied. Two independent experiments were carried out: 1st Experiment Strains: TA 1535, TA 100, TA 1537, TA 98, E. coli WP2 uvrA Doses: 0; 20; 100; 500; 2500 and 5000 µg/plate Vehicle: Water Type of test: Standard plate test with and without S-9 mix Number of plates: 3 test plates per dose or per control 2nd Experiment Strains: TA 1535, TA 100, TA 1537, TA 98, E. coli WP2 uvrA Doses: 0; 20; 100; 500; 2500 and 5000 µg/plate Vehicle: Water Type of test: Preincubation test with and without S-9 mix Number of plates: 3 test plates per dose or per control Negative controls treated with the vehicle (water) and positive controls treated with 2-aminoanthracene, N-methyl-N'-nitro-N-nitrosoguanidine, 4-nitro-o-phenylendiamine, 9-aminoacridine, or 4-nitroquinoline-N-oxide were included in each replicate.
No increase in the number of revertants was observed with any tester strain at any concentration in the absence and presence of metabolic activation. No bacteriotoxicity was observed. The test substance was completely soluble in the vehicle; no precipitation was noted.
According to the results of the present study, DL-Panthenol was considered to be not mutagenic.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
Bacterial reverse mutation assay:
The substance DL-Panthenol was tested for its mutagenic potential based on the ability to induce point mutations in selected loci of several bacterial strains, i.e. Salmonella typhimurium and Escherichia coli, in a reverse mutation assay. Standard plate test (SPT) and Preincubation Test (PIT) both with and without metabolic activation with liver homogenate of Aroclor 1254 -pretreated male Sprague-Dawley rats were applied. Two independent experiments were carried out: 1st Experiment Strains: TA 1535, TA 100, TA 1537, TA 98, E. coli WP2 uvrA Doses: 0; 20; 100; 500; 2500 and 5000 µg/plate Vehicle: Water Type of test: Standard plate test with and without S-9 mix Number of plates: 3 test plates per dose or per control 2nd Experiment Strains: TA 1535, TA 100, TA 1537, TA 98, E. coli WP2 uvrA Doses: 0; 20; 100; 500; 2500 and 5000 µg/plate Vehicle: Water Type of test: Preincubation test with and without S-9 mix Number of plates: 3 test plates per dose or per control Negative controls treated with the vehicle (water) and positive controls treated with 2-aminoanthracene, N-methyl-N'-nitro-N-nitrosoguanidine, 4-nitro-o-phenylendiamine, 9-aminoacridine, or 4-nitroquinoline-N-oxide were included in each replicate. According to the results of the present study, DL-Panthenol was considered to be not mutagenic.
Mammalian cell gene assay:
Read across to the supporting substance DL-Ethylpanthenol was done. For justification of read across please refer to the attachment in IUCLID5 section 13. In a mammalian cell gene mutation assay, in chinese hamster V79 cells cultured in vitro were exposed for 4 hours to DL-Ethyl Panthenol, at concentrations of 150, 300, 600, 1200, 2400 µg/mL in the presence and absence of mammalian metabolic activation S9 mix (rat liver). In a second test the chinese hamster V79 cell cultures were exposed to the same concentrations for 24 hours in the absence of metabolic activation. DL-Ethyl Panthenol was tested up to concentrations of 2400 µg/mL (approx 10 mM). No relevant cytotoxic effect was observed in the first experiment as relative cloning efficiency 1 did not go below 50 %. In the second experiment cytotoxicity was noted at 300 µg/mL and above. No substantial dose dependent increase of the mutation frequency exceeding the threshold of three times the mutation frequency of the corresponding solvent control occured with and without metabolic activation. Furthermore there was no dose dependent trend even below the threshold mentioned above as indicated by the missing statistical significance. Therefore, the data of this study are judged as non-mutagenic. The positive controls induced a distinct increase in mutant colonies and thus, showed the sensitivity of the test and the activity of the metabolic activation system. This study is classified as acceptable. This study fulfills the requirements of the Guideline OECD 476 for in vitro mutagenicity (mammalian forward gene mutation) data.
Chromosome aberration assay:
Read across to the supporting substance DL-Ethylpanthenol was done. For justification of read across please refer to the attachment in IUCLID5 section 13. DL-Ethyl Panthenol was assessed as to its ability to induce chromosomal aberrations in human peripheral blood lymphocytes in vitro.Without metabolic activation doses between 333 and 5000 µg/mL were tested after 24 hours continous treatment. With metabolic activation (S9- mix, rat) doses between 1000 and 5000 µg/mL were tested after a 3 hours pulse treatment. Two independent experiments were performed at a fixation period of 24 hours. Additionally the highest dose of 5000 µg/mL was tested in one experiment at a fixation period of 48 hours (i.e. after a 48 h continuous treament in absence and a 3 hours pulse treatment in presence of S9- mix).
The sensitivity of the test system and the activity of the metabolic activation were demonstrated by using the direct acting mutagen mitomycin-C (MMC-C) and the promutagen cyclophosphamide (CP) as positive controls. Both substances increased significantly the rate of chromosome aberrations.
The highest dose assayed was the maximal recommended one. Cytotoxicity as measured by reductions in the mitotic indices (MI) was observed after continuous (24 and 48 hours) exposures to DL-Ethyl Panthenol in both experiments. Exposure to DL-Ethyl Panthenol did not raise the rate of cells with chromosome aberrations.
Based on the close structural similarity of D-and DL-Panthenol and due to the metabolism of DL Ethyl Panthenol to Panthenol it can be assumed that also DL-Panthenol is neither genotoxic nor mutagenic.
Justification for selection of genetic toxicity endpoint
GLP and guideline study.
Justification for classification or non-classification
Based on the results obtained from the key study and the results of tests performed with the supporting substance, DL-Panthenol was not classified and labeled according to Regulation (EC) No 1272/2008 (CLP) and Directive 67/548/EEC (DSD).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.